Delek Us Holdings surged 10.55% intraday, driven by a Q3 adjusted EPS of $7.13 (far exceeding the IBES estimated loss of $0.59), Q3 revenue of $2.887 billion (beating analyst forecasts by $50 million), and an upward revision of its 2025 adjusted EBITDA guidance to $5–5.2 billion, aligning with the upper end of its prior range.
Comments
No comments yet